Treg Immunotherapy in Crohn's Disease
NCT03185000
·
clinicaltrials.gov ↗
PHASE1
Phase
UNKNOWN
Status
4
Enrollment
OTHER
Sponsor class
Conditions
Crohn Disease
Interventions
DRUG:
TR004 (Treg immunotherapy)
Sponsor
King's College London
Collaborators
[object Object]
[object Object]
[object Object]
[object Object]